Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2006) 11 P612

ECE2006 Poster Presentations Neuroendocrinology and behaviour (70 abstracts)

Positive correlation between AcroQol and SF-36 and negative with BDI in sample of 60 acromegalics

M Abreu 2 , D Carvalho 1 , E Vinha 1 , S Webb 3 & JL Medina 1

1Department of Endocrinology, Universidade do Porto Medical School/ Hospital de S. João, Porto, Portugal; 2Universidade Fernando Pessoa Faculty of Psychology, Porto, Portugal; 3Servivio de Endcrinologia Hospital de Sant Pau Universitate Autónoma de Barcelona, Barcelona, Spain.

Quality of Life (QoL) is a very important issue in the management of a chronic disease like acromegaly. Recently the AcroQol questionnaire was developed to evaluate the QoL in different acromegalic populations. We decided to compare the scores of AcroQol and 2 other different questionnaires: one related to general well-being (SF-36) and the other to evaluate depression (BDI). We preformed a cross-sectional evaluation of a sample of 60 Portuguese acromegalics, 20 men and 40 women, with an average age of 52.7 y, and mean disease duration of 11.2 y followed at the Department of Endocrinology. We defined controlled disease (CA) as normal IGF-1 for age and sex, and GH levels lower than 1 ng/ml during OGTT and 75% of the samples of a 12 hours profile lower than 1 ng/ml. 51 patients were submitted to surgery, 31 to radiotherapy and 29 to medical therapy (octreotide n=20, and lanreotide n=9), and 4 were naive. Twenty-nine patients presented hypopituitarism. Fifty patients were considered controlled and the other 10 uncontrolled. The results are presented as mean+S.D., compared using either Student’s t or Mann-Whitney test as appropriated, and correlation was evaluated using Pearson test. The total score of AcroQol was 49.9+19.3 and had an alpha Cronbach reliability and internal consistency of 0.92. The total score is significantly correlated with SF-36 score (107.7+11.3, r=0.71) and negatively with the BDI score (16.5+13.1, r=−0.76). The AcroQol total score of CA was not significantly different from the uncontrolled ones (UCA) (50.9+19.4 vs 45.2+19.1). The same was observed regarding the AcroQol physical scale (CA 47.6+25.8 vs UCA 44.1+25.1) and psychological scale (CA 52.9+18.5 vs UCA 45.9+20.3), although CA tended to be better than UCA. The discrepancy with the previously presented results may be explained by a high number of patients with hypopituitarism. We conclude that the Portuguese version of AcroQol is a valuable tool to evaluate the QoL of acromegalic patients but hypopituitarism could be a confounding factor.

Volume 11

8th European Congress of Endocrinology incorporating the British Endocrine Societies

European Society of Endocrinology 
British Endocrine Societies 

Browse other volumes

Article tools

My recent searches

No recent searches.